Fresenius Medical Care has sold its dialysis clinic networks in Brazil, Colombia, Chile, and Ecuador to DaVita Inc. for USD 300 million as part of its portfolio optimization strategy, with the deal expected to close throughout 2024.

Target Information

Fresenius Medical Care, renowned globally as the leading provider of products and services for individuals suffering from renal diseases, has announced the divestment of its dialysis clinic networks in Latin America. This transaction, amounting to USD 300 million, involves the sale of 154 clinics across Brazil, Colombia, Chile, and Ecuador to DaVita Inc. This strategic move further reduces the company’s presence in the region as it exited Argentina at the end of 2023.

The sale encompasses over 7,100 employees and serves more than 30,000 dialysis patients, contributing an estimated pro-forma revenue of approximately EUR 370 million for the year 2023. The completion of this deal is contingent upon regulatory approvals in Brazil, Colombia, and Ecuador, with expectations set for closure throughout 2024.

Industry Overview in Latin America

The healthcare sector in Latin America, particularly in renal care, has experienced substantial growth due to an increasing prevalence of chronic conditions and an aging populati